These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7852496

  • 1. Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.
    Azziz R, Bradley EL, Potter HD, Boots LR.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):400-5. PubMed ID: 7852496
    [Abstract] [Full Text] [Related]

  • 2. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
    Azziz R, Rafi A, Smith BR, Bradley EL, Zacur HA.
    J Clin Endocrinol Metab; 1990 Feb; 70(2):431-6. PubMed ID: 2137133
    [Abstract] [Full Text] [Related]

  • 3. Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation.
    Azziz R, Wells G, Zacur HA, Acton RT.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1327-31. PubMed ID: 1955515
    [Abstract] [Full Text] [Related]

  • 4. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
    Azziz R, Bradley EL, Potter HD, Boots LR.
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
    [Abstract] [Full Text] [Related]

  • 5. Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women.
    Azziz R, Bradley EL, Potter HD, Parker CR, Boots LR.
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1251-6. PubMed ID: 7726265
    [Abstract] [Full Text] [Related]

  • 6. Insulin inhibits adrenal 17,20-lyase activity in man.
    Nestler JE, McClanahan MA, Clore JN, Blackard WG.
    J Clin Endocrinol Metab; 1992 Feb; 74(2):362-7. PubMed ID: 1730815
    [Abstract] [Full Text] [Related]

  • 7. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
    Moran C, Reyna R, Boots LS, Azziz R.
    Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
    [Abstract] [Full Text] [Related]

  • 8. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 9. Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time.
    Azziz R, Bradley E, Huth J, Boots LR, Parker CR, Zacur HA.
    J Clin Endocrinol Metab; 1990 May; 70(5):1273-9. PubMed ID: 2139878
    [Abstract] [Full Text] [Related]

  • 10. 17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation.
    Sahin Y, Keleştimur F.
    Hum Reprod; 1997 May; 12(5):910-3. PubMed ID: 9194638
    [Abstract] [Full Text] [Related]

  • 11. Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women.
    Azziz R, Zacur HA, Parker CR, Bradley EL, Boots LR.
    Fertil Steril; 1991 Sep; 56(3):427-33. PubMed ID: 1894020
    [Abstract] [Full Text] [Related]

  • 12. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome.
    Zhou R, Bird IM, Dumesic DA, Abbott DH.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6630-7. PubMed ID: 16174719
    [Abstract] [Full Text] [Related]

  • 13. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha.
    Escobar-Morreale H, Pazos F, Potau N, García-Robles R, Sancho JM, Varela C.
    Fertil Steril; 1994 Sep; 62(3):521-30. PubMed ID: 8062947
    [Abstract] [Full Text] [Related]

  • 14. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB, Ehrmann DA, Brigell DF, Rosenfield RL.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [Abstract] [Full Text] [Related]

  • 15. Lack of an ovarian function influence on the increased adrenal androgen secretion present in women with functional ovarian hyperandrogenism.
    Escobar-Morreale HF, Serrano-Gotarredona J, García-Robles R, Sancho JM, Varela C.
    Fertil Steril; 1997 Apr; 67(4):654-62. PubMed ID: 9093190
    [Abstract] [Full Text] [Related]

  • 16. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R, Black V, Hines GA, Fox LM, Boots LR.
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [Abstract] [Full Text] [Related]

  • 17. Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity.
    Moghetti P, Castello R, Negri C, Tosi F, Spiazzi GG, Brun E, Balducci R, Toscano V, Muggeo M.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):881-6. PubMed ID: 8772544
    [Abstract] [Full Text] [Related]

  • 18. 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis.
    Azziz R, Zacur HA.
    J Clin Endocrinol Metab; 1989 Sep; 69(3):577-84. PubMed ID: 2547827
    [Abstract] [Full Text] [Related]

  • 19. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 20. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R, Black VY, Knochenhauer ES, Hines GA, Boots LR.
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.